FIBROGEN INC Human Resources Contracts & Agreements
21 Contracts & Agreements
- Bonus & Incentive Agreements (5 contracts)
- Change of Control Agreements (3)
- Compensation Agreements (8)
- Consulting Agreements (3)
- Transition Agreements (2)
- FibroGen, Inc. 2024 Equity Incentive Plan (Filed With SEC on June 7, 2024)
- Non-Employee Director Compensation Policy, as amended, dated April 22, 2024 (Filed With SEC on May 6, 2024)
- Termination and Transition Agreement to Development and Commercialization Agreement (for the U.S. and Certain Other Territories), by and between AstraZeneca AB and FibroGen, Inc.,... (Filed With SEC on May 6, 2024)
- FibroGen, Inc. Bonus Plan (Filed With SEC on February 26, 2024)
- Consulting Agreement, dated September 11, 2023, between FibroGen, Inc. and Mark Eisner (Filed With SEC on September 6, 2023)
- Consulting Agreement, dated July 23, 2023, between FibroGen, Inc. and Enrique Conterno (Filed With SEC on July 25, 2023)
- Transition Agreement by and between FibroGen, Inc. and Pat Cotroneo, dated as of August 14, 2021 (Filed With SEC on November 9, 2021)
- Transition, Separation, and Consulting Agreement by and between FibroGen, Inc. and K. Peony Yu, dated as of November 27, 2020 (Filed With SEC on May 10, 2021)
- FibroGen, Inc. Non-Employee Director Compensation Policy, as amended (Filed With SEC on May 7, 2020)
- Form of Executive Officer Change in Control and Severance Agreement (Filed With SEC on March 2, 2020)
- FibroGen, Inc. Non-Employee Director Compensation Policy, as amended (Filed With SEC on November 12, 2019)
- FibroGen, Inc. Non-Employee Director Compensation Policy, as amended (Filed With SEC on August 8, 2019)
- FibroGen, Inc. Non-Employee Director Compensation Policy, as amended (Filed With SEC on August 7, 2018)
- Bonus Plan, adopted February 13, 2018 (Filed With SEC on February 16, 2018)
- FIBROGEN, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on May 9, 2017)
- FibroGen, Inc. Non-Employee Director Compensation Policy Adopted: September 17, 2014 Amended: March 4, 2015 Amended: February 23, 2016, Effective as of the 2016 Annual Meeting of... (Filed With SEC on May 9, 2016)
- FibroGen, Inc. Non-Employee Director Compensation Policy Adopted: September 17, 2014 Amended: March 4, 2015 Effective as of: The effective date of the initial public offering (Filed With SEC on March 26, 2015)
- FIBROGEN, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 09, 2014 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 30, 2014 IPO DATE/EFFECTIVE DATE:[ ], 2014 (Filed With SEC on November 12, 2014)
- FIBROGEN, INC. CHANGEIN CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on October 24, 2014)
- FIBROGEN, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 09, 2014 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 30, 2014 IPO DATE/EFFECTIVE DATE:[ ], 2014 (Filed With SEC on October 24, 2014)
- FibroGen, Inc. Non-Employee Director Compensation Policy Adopted: September 17, 2014 Effective as of: The effective date of the initial public offering (Filed With SEC on October 23, 2014)
